APA

Dimitroulopoulos D., Elefsiniotis I., Pavlidis C., Xinopoulos D., Tsamakidis K., Patsavela S., Kypreos D., Ferderigou A., Korkolis D., Koutsounas S., Saroglou G. & Paraskevas E. (20120828). European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response. : Hepatitis monthly.

Chicago

Dimitroulopoulos Dimitrios, Elefsiniotis Ioannis, Pavlidis Christos, Xinopoulos Dimitrios, Tsamakidis Klisthenis, Patsavela Stamatina, Kypreos Dimitrios, Ferderigou Ageliki, Korkolis Dimitrios, Koutsounas Sotirios, Saroglou Georgios and Paraskevas Emmanouil. 20120828. European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response. : Hepatitis monthly.

Harvard

Dimitroulopoulos D., Elefsiniotis I., Pavlidis C., Xinopoulos D., Tsamakidis K., Patsavela S., Kypreos D., Ferderigou A., Korkolis D., Koutsounas S., Saroglou G. and Paraskevas E. (20120828). European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response. : Hepatitis monthly.

MLA

Dimitroulopoulos Dimitrios, Elefsiniotis Ioannis, Pavlidis Christos, Xinopoulos Dimitrios, Tsamakidis Klisthenis, Patsavela Stamatina, Kypreos Dimitrios, Ferderigou Ageliki, Korkolis Dimitrios, Koutsounas Sotirios, Saroglou Georgios and Paraskevas Emmanouil. European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response. : Hepatitis monthly. 20120828.